GEODE CAPITAL MANAGEMENT, LLC

Position in JNJ — Johnson & Johnson

CIK 1214717 BOSTON, MA

Back to JNJ Full portfolio

Position in JNJ

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$14,462,258,866

+$2,468,730,926 QoQ

Shares Held

59,164,862

+2.1% QoQ

Ownership

2.46%

of shares outstanding

% of Portfolio

0.92%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2020

25 quarters on record

Voting authority Sole 99.92043419284913.ToString("F0")% Shared 0.ToString("F0")% None 0.07956580715087276.ToString("F0")%

Common Shares in JNJ Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - General

Healthcare · as of Mar 31, 2026

GEODE CAPITAL MANAGEMENT, LLC holds $67,874,952,284 across 14 Drug Manufacturers - General names. JNJ ranks #2 (21.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co	20,191,864	$18,571,870,750
2	JNJ	Johnson & Johnson This page	59,164,862	$14,462,258,866
3	ABBV	AbbVie Inc.	46,737,581	$10,164,956,491
4	MRK	Merck & Co., Inc.	59,558,154	$7,164,250,343
5	AMGN	Amgen Inc	15,430,524	$5,429,229,869
6	GILD	Gilead Sciences, Inc.	29,726,052	$4,142,919,866
7	PFE	Pfizer Inc	133,561,742	$3,750,413,715
8	BMY	Bristol Myers Squibb Co	55,286,174	$3,353,106,452

All Filings in JNJ

Export CSV

25 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$14,462,258,866	59,164,862	+2.1%	Shares	Defined	2026-05-15
2025-12-31	$11,993,527,940	57,953,747	+3.1%	Shares	Defined	2026-02-09
2025-09-30	$10,423,469,665	56,215,455	-7.2%	Shares	Defined	2025-11-12
2025-06-30	$9,258,097,458	60,609,476	+2.1%	Shares	Defined	2025-08-08
2025-03-31	$9,848,209,391	59,383,800	+3.0%	Shares	Defined	2025-05-13
2024-12-31	$8,339,934,590	57,667,920	+2.8%	Shares	Defined	2025-02-12
2024-09-30	$9,092,681,620	56,106,884	+1.8%	Shares	Defined	2024-11-12
2024-06-30	$8,053,726,004	55,102,121	+3.3%	Shares	Defined	2024-08-09
2024-03-31	$8,435,159,675	53,322,964	+4.0%	Shares	Defined	2024-05-13
2023-12-31	$8,033,988,480	51,256,785	+9.0%	Shares	Defined	2024-02-13
2023-09-30	$7,326,795,238	47,042,024	-5.3%	Shares	Defined	2023-11-13
2023-06-30	$8,225,979,524	49,697,798	+2.0%	Shares	Defined	2023-08-11
2023-03-31	$7,549,662,500	48,707,500	+1.6%	Shares	Defined	2023-05-15
2022-12-31	$8,471,883,686	47,958,583	+0.6%	Shares	Defined	2023-02-13
2022-09-30	$7,786,376,664	47,663,912	+2.0%	Shares	Defined	2022-11-14
2022-06-30	$8,291,049,567	46,707,507	+3.7%	Shares	Defined	2022-08-12
2022-03-31	$7,979,168,597	45,021,546	+1.4%	Shares	Defined	2022-05-13
2021-12-31	$7,596,467,702	44,405,610	+2.5%	Shares	Defined	2022-02-11
2021-09-30	$6,996,305,324	43,320,776	+2.6%	Shares	Defined	2021-11-12
2021-06-30	$6,954,372,579	42,214,232	+3.4%	Shares	Defined	2021-08-13
2021-03-31	$6,709,628,358	40,825,241	+1.8%	Shares	Defined	2021-05-12
2020-12-31	$6,312,370,944	40,109,105	+1.4%	Shares	Defined	2021-02-12
2020-09-30	$5,887,135,636	39,542,824	-0.1%	Shares	Defined	2020-11-13
2020-06-30	$5,565,254,634	39,573,737	+1.6%	Shares	Defined	2020-08-13
2020-03-31	$5,109,500,905	38,965,156	—	Shares	Defined	2020-05-14
No filing history on record for this holder in this stock.